1. Home
  2. SRRK vs ENVA Comparison

SRRK vs ENVA Comparison

Compare SRRK & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$47.76

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$235.95

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
ENVA
Founded
2012
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.8B
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
SRRK
ENVA
Price
$47.76
$235.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
7
Target Price
$56.17
$185.71
AVG Volume (30 Days)
1.2M
382.4K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.05
EPS
N/A
7.45
Revenue
N/A
$3,151,653,000.00
Revenue This Year
N/A
$149.64
Revenue Next Year
$534.24
$16.42
P/E Ratio
N/A
$62.95
Revenue Growth
N/A
18.58
52 Week Low
$27.07
$99.61
52 Week High
$58.49
$246.38

Technical Indicators

Market Signals
Indicator
SRRK
ENVA
Relative Strength Index (RSI) 39.63 61.43
Support Level $45.46 $220.13
Resistance Level $48.23 $246.38
Average True Range (ATR) 2.44 8.73
MACD -1.01 -3.01
Stochastic Oscillator 6.24 78.13

Price Performance

Historical Comparison
SRRK
ENVA

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: